Tag Archives: Sebastian Grabert

Europe frets over waning IPO biotech scene while US pricings and new registrations keep chugging along.

The News: Over the last two weeks, several biotech companies in Europe have decided to postpone IPOs on the stock markets there prompting speculation that biotech stocks are underperforming, according… Read more »